Cold Chain Market for Pharmaceuticals: Distribution by Type of Primary Packaging (Vials, Ampoules, Pre-filled Syringes and Bags), Type of Secondary Packaging (Cold Boxes, Vaccine Carriers and Insulated Containers), Type of Usability (Reusable and Single-use) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, Latin America and Rest of the World): Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
The global cold chain market is expected to reach USD 6.2 billion in 2023 anticipated to grow at a CAGR of 3.7% during the forecast period 2023-2035.
The cold chain system is a complex, well-coordinated process that manages temperature-sensitive materials during storage and transportation. It relies on various tools like cold chain shippers, insulated containers, and monitoring devices such as data loggers. Widely used in food, dairy, chemical, and pharmaceutical industries, its main aim is to prolong the shelf life of perishable items like fresh produce, vaccines, and medicines, ensuring their quality remains intact. Specifically in pharmaceuticals, it caters to strict temperature needs, ensuring the integrity of biologics, COVID vaccines, and organ transplants. Recent advances in monitoring, like temperature sensors and real-time tracking, have significantly improved efficiency by enabling continuous monitoring during shipment.
However, challenges persist, especially in packaging and temperature control during pharmaceutical storage and transport. In some areas, inadequate packaging and temperature management lead to a significant portion of drugs losing effectiveness. Unexpected issues such as equipment failures or exposure to high temperatures can disrupt the cold chain, risking damage or contamination. To tackle these challenges, industry players are exploring hybrid solutions that integrate temperature data loggers into cold chain containers. This integration offers better visibility and more efficient tracking of pharmaceutical shipments, presenting a promising alternative to traditional packaging. With ongoing advancements and industry efforts driving growth, the pharmaceutical cold chain market is expected to expand significantly in the foreseeable future.
Report Coverage
The cold chain system is a complex, well-coordinated process that manages temperature-sensitive materials during storage and transportation. It relies on various tools like cold chain shippers, insulated containers, and monitoring devices such as data loggers. Widely used in food, dairy, chemical, and pharmaceutical industries, its main aim is to prolong the shelf life of perishable items like fresh produce, vaccines, and medicines, ensuring their quality remains intact. Specifically in pharmaceuticals, it caters to strict temperature needs, ensuring the integrity of biologics, COVID vaccines, and organ transplants. Recent advances in monitoring, like temperature sensors and real-time tracking, have significantly improved efficiency by enabling continuous monitoring during shipment.
However, challenges persist, especially in packaging and temperature control during pharmaceutical storage and transport. In some areas, inadequate packaging and temperature management lead to a significant portion of drugs losing effectiveness. Unexpected issues such as equipment failures or exposure to high temperatures can disrupt the cold chain, risking damage or contamination. To tackle these challenges, industry players are exploring hybrid solutions that integrate temperature data loggers into cold chain containers. This integration offers better visibility and more efficient tracking of pharmaceutical shipments, presenting a promising alternative to traditional packaging. With ongoing advancements and industry efforts driving growth, the pharmaceutical cold chain market is expected to expand significantly in the foreseeable future.
Report Coverage
- The report comprehensively examines the pharmaceutical cold chain market, focusing on primary packaging type of primary packaging, type of secondary packaging, type of usability and key geographical regions.
- It conducts a thorough analysis of the market's growth influencers, encompassing drivers, restraints, opportunities, and challenges.
- Evaluation of potential advantages and obstacles within the market landscape is provided, along with insights into the competitive environment for leading market players.
- Revenue forecasts for market segments are presented concerning six major regions.
- Detailed insights into the research methodology are offered, covering methodologies, assumptions, and quality control measures to ensure precision and reliability of findings.
- Historical trends, currency fluctuations, foreign exchange impacts, and economic measures impacting the overall pharmaceutical cold chain market are examined.
- A comprehensive overview of the current status and anticipated future developments in the pharmaceutical cold chain market over the mid-to-long term is presented.
- An exploration of cold chain packaging, its historical evolution, diverse packaging solutions, pharmaceutical applications, existing challenges, and future prospects is provided.
- Comprehensive evaluations of 72 cold chain container/shipper providers and 70 data logger providers are conducted, considering various parameters such as establishment year, company size, product types, and technological aspects.
- Comparative analysis of key focus areas among cold chain container/shipper providers in North America, Europe, and Asia-Pacific is presented, aiding stakeholders in identifying competitive advantages.
- Detailed profiles of key cold chain container/shipper providers, including company overview, product portfolios, recent developments, and future outlook, are outlined.
- Examination of partnerships, collaborations, mergers, and acquisitions among stakeholders, including partnership types, applications, and active industry players since 2019, is provided.
- In-depth exploration of patents filed or granted since 2019, encompassing publication and application years, organizations, leading industry players, and valuation analysis, is conducted.
- Detailed discussion on regulatory guidelines issued by international and regional authorities is presented, offering recommendations for different stages of the cold chain process along with a comparative analysis of regulatory bodies.
- Analysis of emerging trends, growth opportunities, technological advancements, real-time monitoring, integration methods, and associated benefits in the pharmaceutical cold chain industry is provided.
- Comprehensive analysis of factors influencing the growth of the pharmaceutical cold chain market, including drivers, restraints, opportunities, and challenges, is included.
- Cold Chain Technologies
- Cryopak
- CSafe
- EMBALL’ISO
- Intelsius
- Nordic Cold Chain Solutions
- Peli BioThermal
- SEE
- SOFRIGAM
- Sonoco Thermosafe
- Tempack
1. PREFACE
1.1. Cold Chain Market for Pharmaceuticals
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Introduction to Cold Chain Packaging
5.3. Historical Timeline of Cold Chain
5.4. Cold Chain Solutions for Pharmaceutical Industry
5.4.1. Cold Chain Packaging Solutions: Containers and Shippers
5.4.1.1. Active Cold Chain Packaging Solutions
5.4.1.2. Passive Cold Chain Packaging Solutions
5.4.1.3. Insulated Cold Chain Packaging Solutions
5.4.2. Cold Chain Monitoring Solutions: Data Loggers
5.4.2.1. Data Loggers
5.4.2.2. Indicators
5.5. Applications of Cold Chain in Pharmaceutical Industry
5.6. Current Challenges and Future Perspectives
6. OVERALL MARKET LANDSCAPE: COLD CHAIN CONTAINER / SHIPPER PROVIDERS
6.1. Chapter Overview
6.2. Cold Chain Container / Shipper Providers: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Type of Cold Chain Solution
6.2.6. Analysis by Type of Product Offered
6.2.7. Analysis by Type of Product Material
6.2.8. Analysis by Type of Product Packaged
6.2.9. Analysis by Storage Temperature
6.2.10. Analysis by Type of Service Offered
6.2.11. Analysis by Company Size and Type of Service Offered
7. OVERALL MARKET LANDSCAPE: DATA LOGGER PROVIDERS
7.1. Chapter Overview
7.2. Data Logger Providers: Overall Market Landscape
7.3. Analysis by Year of Establishment
7.4. Analysis by Company Size
7.5. Analysis by Location of Headquarters (Region)
7.6. Analysis by Location of Headquarters (Country)
7.7. Analysis by Type of Product Offered
7.8. Analysis by Mode of Data Transmission
7.9. Analysis by Type of Data Captured
7.10. Analysis by Type of Pharmaceutical Monitored
7.11. Analysis by Temperature Range
7.12. Analysis by Type of Product Offered and Mode of Data Transmission
7.13. Analysis by Type of Product Offered and Type of Data Captured
8. COMPETITIVE BENCHMARKING
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Competitive Benchmarking of Cold Chain Container / Shipper Providers
8.3.1. Competitive Benchmarking: Players based in North America (Peer Group I)
8.3.2. Competitive Benchmarking: Players based in Europe (Peer Group II)
8.3.3. Competitive Benchmarking: Large Players based in Asia-Pacific and RoW (Peer Group III)
8.4. Concluding Remarks
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Cold Chain Technologies
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Service Portfolio
9.2.4. Recent Developments and Future Outlook
9.3. Cryopak
9.3.1. Company Overview
9.3.2. Product Portfolio
9.3.3. Service Portfolio
9.3.4. Recent Developments and Future Outlook
9.4. CSafe
9.4.1. Company Overview
9.4.2. Product Portfolio
9.4.3. Service Portfolio
9.4.4. Recent Developments and Future Outlook
9.5. EMBALL'ISO
9.5.1. Company Overview
9.5.2. Product Portfolio
9.5.3. Service Portfolio
9.5.4. Recent Developments and Future Outlook
9.6. Intelsius
9.6.1. Company Overview
9.6.2. Product Portfolio
9.6.3. Service Portfolio
9.6.4. Recent Developments and Future Outlook
9.7. Nordic Cold Chain Solutions
9.7.1. Company Overview
9.7.2. Product Portfolio
9.7.3. Service Portfolio
9.7.4. Recent Developments and Future Outlook
9.8. Peli BioThermal
9.8.1. Company Overview
9.8.2. Product Portfolio
9.8.3. Service Portfolio
9.8.4. Recent Developments and Future Outlook
9.9. SEE
9.9.1. Company Overview
9.9.2. Product Portfolio
9.9.3. Service Portfolio
9.9.4. Recent Developments and Future Outlook
9.10. SOFRIGAM
9.10.1. Company Overview
9.10.2. Product Portfolio
9.10.3. Service Portfolio
9.10.4. Recent Developments and Future Outlook
9.11. Sonoco Thermosafe
9.11.1. Company Overview
9.11.2. Product Portfolio
9.11.3. Service Portfolio
9.11.4. Recent Developments and Future Outlook
9.12. Tempack
9.12.1. Company Overview
9.12.2. Product Portfolio
9.12.3. Service Portfolio
9.12.4. Recent Developments and Future Outlook
9.13. Other Leading Players
9.13.1. Almac
9.13.2. B Medical Systems
9.13.3. BioLife Solutions
9.13.4. CRS Mobile Cold Storage
9.13.5. Desert Valley Tech
9.13.6. Dubai Instruments
9.13.7. Envirotainer
9.13.8. Global Cold Chain Solutions (Headquartered in Australia)
9.13.9. Global Cold Chain Solutions (Headquartered in Singapore)
9.13.10. Klinge
9.13.11. Krautz-temax
9.13.12. Meds2go
9.13.13. phasetwo
9.13.14. Polar Tech Industries
9.13.15. Skycell
9.13.16. UPS Healthcare
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Cold Chain for Pharmaceuticals: Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Application Area
10.3.5. Analysis by Type of Product / Technology
10.3.6. Analysis by Geography
10.3.6.1. Local and International Agreements
10.3.6.2. Intercontinental and Intracontinental Agreements
10.3.7 Most Active Players: Analysis by Number of Partnerships
10.4. Cold Chain for Pharmaceuticals: Acquisitions
10.4.1. Analysis by Year of Acquisition
10.4.2. Analysis by Type of Acquisition
10.4.2. Analysis by Year and Type of Acquisition
10.4.3. Analysis by Application Area
10.4.4. Analysis by Type of Product / Technology
10.4.5. Analysis by Geography
10.4.5.1. Local and International Agreements
10.4.5.2. Intercontinental and Intracontinental Agreements
10.4.6. Ownership Change Matrix
10.4.7. Analysis by Key Value Drivers
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Cold Chain for Pharmaceuticals: Patent Analysis
11.3.1. Analysis by Type of Patent
11.3.2. Analysis by Publication Year
11.3.3. Analysis by Type of Patent and Publication Year
11.3.4. Analysis by Application Year
11.3.5. Analysis by Type of Organization
11.3.6. Analysis by Patent Jurisdiction
11.3.7. Analysis by CPC Symbols
11.3.8. Analysis by Emerging Focus Area
11.3.9. Leading Industry Players: Analysis by Number of Patents
11.4. Cold Chain for Pharmaceuticals: Patent Benchmarking Analysis
11.4.1. Analysis by Patent Characteristics
11.4.1.1. Cold Chain Technologies and Ember LifeSciences
11.4.1.2. Other Leading Patent Assignees
11.5. Patent Valuation Analysis
12. REGULATORY RECOMMENDATIONS AND GUIDELINES
12.1. Chapter Overview
12.2. Regulatory Guidelines Issued by International Authorities
12.2.1. World Health Organization (WHO)
12.2.2. International Air Transport Association (IATA)
12.2.3. International Safe Transit Association (ISTA)
12.3. Regulatory Guidelines Issued by Regional Authorities
12.3.1. Regulatory Guidelines for Cold Chain Management in the US
12.3.1.1. United States Food and Drug Administration (USFDA)
12.3.2. United States Pharmacopeia (USP)
12.3.3. Regulatory Guidelines for Cold Chain Management in Canada
12.3.3.1. Health Canada
12.3.4. Regulatory Guidelines for Cold Chain Management in Europe
12.3.4.1. European Medicine Agency
12.4. Recommendations for Different Steps of Cold Chain
12.5. Comparative Analysis of Regulatory Authorities
13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Connected Cold Chain: Key Tools and Technologies
13.2.1. Artificial Intelligence
13.2.2. Augmented Reality
13.2.3. Automation and Robotics
13.2.4. Big Data Analytics
13.2.5. Block Chain Technology
13.2.6. Cloud Computing
13.2.7. Internet of Things
13.2.8. Radio Frequency Identification (RFID) Tags
13.3. Connected Cold Chain: Future Growth Opportunities
13.4. Real-Time Monitoring: An Application of Connected Cold Chain Solutions
13.4.1 Methods for Integration of Real-Time Monitoring in Cold Chain
13.4.1.1. RFID Based Real-Time Monitoring
13.4.1.2. Blockchain And IoT Based Real-Time Monitoring
13.4.2. Growth Opportunities for Real-Time Monitoring in Connected Cold Chain
13.4.3. Cost Benefits of Real-Time Monitoring in Cold Chain
14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion
15. COLD CHAIN MARKET FOR PHARMACEUTICALS
15.1. Chapter Overview
15.2. Assumptions and Methodology
15.3. Global Cold Chain Market for Pharmaceuticals, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard
16. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF PRIMARY PACKAGING
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Vials: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.4. Ampoules: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.5. Pre-filled Syringes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.6. Bags: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.7. Data Triangulation
16.7.1. Insights from Primary Research
16.7.2. Insights from Secondary Research
16.7.3. Insights from In-house Repository
17. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF SECONDARY PACKAGING
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Cold Boxes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.4. Vaccine Carriers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.5. Insulated Containers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.6. Data Triangulation
17.6.1. Insights from Primary Research
17.6.2. Insights from Secondary Research
17.7.3. Insights from In-house Repository
18. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF USABILITY
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Reusable Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
18.4. Single-use Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY KEY GEOGRAPHICAL REGIONS
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.4. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.5. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.6. Middle East and North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.7. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035
19.8. Rest of the World: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.9. Data Triangulation
19.9.1. Insights from Primary Research
19.9.2. Insights from Secondary Research
19.9.3. Insights from In-house Repository
20. CONCLUSION
21. EXECUTIVE INSIGHTS
21.1. Chapter Overview
21.2. EMBALL’ISO
21.2.1. Company Snapshot
21.2.2. Interview Transcript
21.3. Tower Cold Chain
21.3.1. Company Snapshot
21.3.2. Interview Transcript
22. APPENDIX 1: TABULATED DATA
23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Cold Chain Market for Pharmaceuticals
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Introduction to Cold Chain Packaging
5.3. Historical Timeline of Cold Chain
5.4. Cold Chain Solutions for Pharmaceutical Industry
5.4.1. Cold Chain Packaging Solutions: Containers and Shippers
5.4.1.1. Active Cold Chain Packaging Solutions
5.4.1.2. Passive Cold Chain Packaging Solutions
5.4.1.3. Insulated Cold Chain Packaging Solutions
5.4.2. Cold Chain Monitoring Solutions: Data Loggers
5.4.2.1. Data Loggers
5.4.2.2. Indicators
5.5. Applications of Cold Chain in Pharmaceutical Industry
5.6. Current Challenges and Future Perspectives
6. OVERALL MARKET LANDSCAPE: COLD CHAIN CONTAINER / SHIPPER PROVIDERS
6.1. Chapter Overview
6.2. Cold Chain Container / Shipper Providers: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Type of Cold Chain Solution
6.2.6. Analysis by Type of Product Offered
6.2.7. Analysis by Type of Product Material
6.2.8. Analysis by Type of Product Packaged
6.2.9. Analysis by Storage Temperature
6.2.10. Analysis by Type of Service Offered
6.2.11. Analysis by Company Size and Type of Service Offered
7. OVERALL MARKET LANDSCAPE: DATA LOGGER PROVIDERS
7.1. Chapter Overview
7.2. Data Logger Providers: Overall Market Landscape
7.3. Analysis by Year of Establishment
7.4. Analysis by Company Size
7.5. Analysis by Location of Headquarters (Region)
7.6. Analysis by Location of Headquarters (Country)
7.7. Analysis by Type of Product Offered
7.8. Analysis by Mode of Data Transmission
7.9. Analysis by Type of Data Captured
7.10. Analysis by Type of Pharmaceutical Monitored
7.11. Analysis by Temperature Range
7.12. Analysis by Type of Product Offered and Mode of Data Transmission
7.13. Analysis by Type of Product Offered and Type of Data Captured
8. COMPETITIVE BENCHMARKING
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Competitive Benchmarking of Cold Chain Container / Shipper Providers
8.3.1. Competitive Benchmarking: Players based in North America (Peer Group I)
8.3.2. Competitive Benchmarking: Players based in Europe (Peer Group II)
8.3.3. Competitive Benchmarking: Large Players based in Asia-Pacific and RoW (Peer Group III)
8.4. Concluding Remarks
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Cold Chain Technologies
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Service Portfolio
9.2.4. Recent Developments and Future Outlook
9.3. Cryopak
9.3.1. Company Overview
9.3.2. Product Portfolio
9.3.3. Service Portfolio
9.3.4. Recent Developments and Future Outlook
9.4. CSafe
9.4.1. Company Overview
9.4.2. Product Portfolio
9.4.3. Service Portfolio
9.4.4. Recent Developments and Future Outlook
9.5. EMBALL'ISO
9.5.1. Company Overview
9.5.2. Product Portfolio
9.5.3. Service Portfolio
9.5.4. Recent Developments and Future Outlook
9.6. Intelsius
9.6.1. Company Overview
9.6.2. Product Portfolio
9.6.3. Service Portfolio
9.6.4. Recent Developments and Future Outlook
9.7. Nordic Cold Chain Solutions
9.7.1. Company Overview
9.7.2. Product Portfolio
9.7.3. Service Portfolio
9.7.4. Recent Developments and Future Outlook
9.8. Peli BioThermal
9.8.1. Company Overview
9.8.2. Product Portfolio
9.8.3. Service Portfolio
9.8.4. Recent Developments and Future Outlook
9.9. SEE
9.9.1. Company Overview
9.9.2. Product Portfolio
9.9.3. Service Portfolio
9.9.4. Recent Developments and Future Outlook
9.10. SOFRIGAM
9.10.1. Company Overview
9.10.2. Product Portfolio
9.10.3. Service Portfolio
9.10.4. Recent Developments and Future Outlook
9.11. Sonoco Thermosafe
9.11.1. Company Overview
9.11.2. Product Portfolio
9.11.3. Service Portfolio
9.11.4. Recent Developments and Future Outlook
9.12. Tempack
9.12.1. Company Overview
9.12.2. Product Portfolio
9.12.3. Service Portfolio
9.12.4. Recent Developments and Future Outlook
9.13. Other Leading Players
9.13.1. Almac
9.13.2. B Medical Systems
9.13.3. BioLife Solutions
9.13.4. CRS Mobile Cold Storage
9.13.5. Desert Valley Tech
9.13.6. Dubai Instruments
9.13.7. Envirotainer
9.13.8. Global Cold Chain Solutions (Headquartered in Australia)
9.13.9. Global Cold Chain Solutions (Headquartered in Singapore)
9.13.10. Klinge
9.13.11. Krautz-temax
9.13.12. Meds2go
9.13.13. phasetwo
9.13.14. Polar Tech Industries
9.13.15. Skycell
9.13.16. UPS Healthcare
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Cold Chain for Pharmaceuticals: Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Application Area
10.3.5. Analysis by Type of Product / Technology
10.3.6. Analysis by Geography
10.3.6.1. Local and International Agreements
10.3.6.2. Intercontinental and Intracontinental Agreements
10.3.7 Most Active Players: Analysis by Number of Partnerships
10.4. Cold Chain for Pharmaceuticals: Acquisitions
10.4.1. Analysis by Year of Acquisition
10.4.2. Analysis by Type of Acquisition
10.4.2. Analysis by Year and Type of Acquisition
10.4.3. Analysis by Application Area
10.4.4. Analysis by Type of Product / Technology
10.4.5. Analysis by Geography
10.4.5.1. Local and International Agreements
10.4.5.2. Intercontinental and Intracontinental Agreements
10.4.6. Ownership Change Matrix
10.4.7. Analysis by Key Value Drivers
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Cold Chain for Pharmaceuticals: Patent Analysis
11.3.1. Analysis by Type of Patent
11.3.2. Analysis by Publication Year
11.3.3. Analysis by Type of Patent and Publication Year
11.3.4. Analysis by Application Year
11.3.5. Analysis by Type of Organization
11.3.6. Analysis by Patent Jurisdiction
11.3.7. Analysis by CPC Symbols
11.3.8. Analysis by Emerging Focus Area
11.3.9. Leading Industry Players: Analysis by Number of Patents
11.4. Cold Chain for Pharmaceuticals: Patent Benchmarking Analysis
11.4.1. Analysis by Patent Characteristics
11.4.1.1. Cold Chain Technologies and Ember LifeSciences
11.4.1.2. Other Leading Patent Assignees
11.5. Patent Valuation Analysis
12. REGULATORY RECOMMENDATIONS AND GUIDELINES
12.1. Chapter Overview
12.2. Regulatory Guidelines Issued by International Authorities
12.2.1. World Health Organization (WHO)
12.2.2. International Air Transport Association (IATA)
12.2.3. International Safe Transit Association (ISTA)
12.3. Regulatory Guidelines Issued by Regional Authorities
12.3.1. Regulatory Guidelines for Cold Chain Management in the US
12.3.1.1. United States Food and Drug Administration (USFDA)
12.3.2. United States Pharmacopeia (USP)
12.3.3. Regulatory Guidelines for Cold Chain Management in Canada
12.3.3.1. Health Canada
12.3.4. Regulatory Guidelines for Cold Chain Management in Europe
12.3.4.1. European Medicine Agency
12.4. Recommendations for Different Steps of Cold Chain
12.5. Comparative Analysis of Regulatory Authorities
13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Connected Cold Chain: Key Tools and Technologies
13.2.1. Artificial Intelligence
13.2.2. Augmented Reality
13.2.3. Automation and Robotics
13.2.4. Big Data Analytics
13.2.5. Block Chain Technology
13.2.6. Cloud Computing
13.2.7. Internet of Things
13.2.8. Radio Frequency Identification (RFID) Tags
13.3. Connected Cold Chain: Future Growth Opportunities
13.4. Real-Time Monitoring: An Application of Connected Cold Chain Solutions
13.4.1 Methods for Integration of Real-Time Monitoring in Cold Chain
13.4.1.1. RFID Based Real-Time Monitoring
13.4.1.2. Blockchain And IoT Based Real-Time Monitoring
13.4.2. Growth Opportunities for Real-Time Monitoring in Connected Cold Chain
13.4.3. Cost Benefits of Real-Time Monitoring in Cold Chain
14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion
15. COLD CHAIN MARKET FOR PHARMACEUTICALS
15.1. Chapter Overview
15.2. Assumptions and Methodology
15.3. Global Cold Chain Market for Pharmaceuticals, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard
16. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF PRIMARY PACKAGING
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Vials: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.4. Ampoules: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.5. Pre-filled Syringes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.6. Bags: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.7. Data Triangulation
16.7.1. Insights from Primary Research
16.7.2. Insights from Secondary Research
16.7.3. Insights from In-house Repository
17. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF SECONDARY PACKAGING
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Cold Boxes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.4. Vaccine Carriers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.5. Insulated Containers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.6. Data Triangulation
17.6.1. Insights from Primary Research
17.6.2. Insights from Secondary Research
17.7.3. Insights from In-house Repository
18. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF USABILITY
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Reusable Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
18.4. Single-use Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY KEY GEOGRAPHICAL REGIONS
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.4. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.5. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.6. Middle East and North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.7. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035
19.8. Rest of the World: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.9. Data Triangulation
19.9.1. Insights from Primary Research
19.9.2. Insights from Secondary Research
19.9.3. Insights from In-house Repository
20. CONCLUSION
21. EXECUTIVE INSIGHTS
21.1. Chapter Overview
21.2. EMBALL’ISO
21.2.1. Company Snapshot
21.2.2. Interview Transcript
21.3. Tower Cold Chain
21.3.1. Company Snapshot
21.3.2. Interview Transcript
22. APPENDIX 1: TABULATED DATA
23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
